4552
JCR Pharmaceuticals Co., Ltd.
2026/01/23
Entered into an exclusive license agreement with Italfarmaco for the Duchenne Muscular Dystrophy treatment Givinostat in Japan, initiating a strategic partnership in rare disease therapeutics.